文献速递关节外科

全羟基磷灰石涂层无骨水泥股骨柄初次全髋关节置换术后30至35年生存率与临床结果

Survival and Clinical Outcomes at 30 to 35 Years Following Primary Total Hip Arthroplasty With a Cementless Femoral Stem Fully Coated With Hydroxyapatite.
PubMed 文献 · J Arthroplasty · 2022-12-08

本研究更新并报告了347例使用无骨水泥双锥度钛全羟基磷灰石涂层股骨柄的初次全髋关节置换术在超过30年随访时的临床结果和生存率。平均随访33年时,32例患者(34髋)仍使用原股骨柄,平均改良Harris髋关节评分为86分,所有患者对手术非常满意或满意。35年时,因任何原因行股骨柄翻修的累积发生率为9.5%(Kaplan-Meier法)和4.5%(累积发生率函数法);因无菌性松动行股骨柄翻修为3.1%(Kaplan-Meier法)和2.1%(累积发生率函数法);任何原因任何组件再手术或翻修为45.3%(Kaplan-Meier法)和26.3%(累积发生率函数法)。

要点

  • 平均随访33年时,32例患者(34髋)仍使用原股骨柄,平均改良Harris髋关节评分为86分。
  • 所有仍使用原股骨柄的患者(100%)对手术非常满意或满意。
  • 35年时因任何原因行股骨柄翻修的累积发生率为9.5%(Kaplan-Meier法)和4.5%(累积发生率函数法)。

核心结论

  • 本研究显示,无骨水泥双锥度钛全羟基磷灰石涂层股骨柄在35年时具有优异的生存率。

研究设计与样本

  • 回顾性队列研究(证据等级IV),纳入347例初次全髋关节置换术,使用无骨水泥双锥度钛全羟基磷灰石涂层股骨柄。

主要发现

  • 平均随访33年(范围31至35年),32例患者(34髋)仍使用原股骨柄,平均改良Harris髋关节评分为86分(范围46至100)。
  • 所有仍使用原股骨柄的患者(100%)对手术非常满意或满意。
  • 35年时因任何原因行股骨柄翻修的累积发生率为9.5%(Kaplan-Meier法)和4.5%(累积发生率函数法)。
  • 35年时因无菌性松动行股骨柄翻修的累积发生率为3.1%(Kaplan-Meier法)和2.1%(累积发生率函数法)。
  • 35年时任何原因任何组件再手术或翻修的累积发生率为45.3%(Kaplan-Meier法)和26.3%(累积发生率函数法)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of the present study was to update and report clinical outcomes and survival of primary total hip arthroplasty using a cementless double-tapered titanium fully hydroxyapatite-coated stem at a follow-up > 30 years. METHODS: The outcomes of this series of 347 primary total hip arthroplasties were already published at a follow-up > 25 years, during which only 12 stems were revised. Since then, there were two additional stem revisions, bringing the total to 14 stem revisions (all of which also required cup revision). Patients still living with the original stem were assessed using the modified Harris Hip Score and patient satisfaction (very satisfied, satisfied, dissatisfied, and very dissatisfied). Revision incidence was calculated using the Kaplan-Meier (KM) method and Cumulative Incidence Function (CIF) at 35 years. RESULTS: At a mean follow-up of 33 years (range, 31 to 35 years), 32 patients (34 hips) were still living with the original stem. Their mean modified Harris Hip Score was 86 points (range, 46 to 100) and all patients (100%) were very satisfied or satisfied with surgery. The revision incidence at 35 years considering (a) stem revision for any reason was 9.5% using KM and 4.5% using CIF; (b) stem revision for aseptic loosening was 3.1% using KM and 2.1% using CIF; and (c) reoperation or revision of any component for any reason was 45.3% using KM and 26.3% using CIF. CONCLUSION: The present study has demonstrated excellent survival at 35 years for a cementless double-tapered titanium fully hydroxyapatite-coated stem. LEVEL OF EVIDENCE: Level IV, Retrospective cohort study.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Jacquot L, Machenaud A, Bonnin MP, et al. Survival and Clinical Outcomes at 30 to 35 Years Following Primary Total Hip Arthroplasty With a Cementless Femoral Stem Fully Coated With Hydroxyapatite. J Arthroplasty. 2022. PMID: 36496046. doi:10.1016/j.arth.2022.11.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。